Dr Reddys Laboratories (RDY) Operating Income (QoQ) (2012 - 2026)

Dr Reddys Laboratories (RDY) Operating Income (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -90.93%
Jun 30, 2025 0.20%
Mar 31, 2025 -8.09%
Dec 31, 2024 5.81%
Sep 30, 2024 -2.48%
Jun 30, 2024 19.29%
Mar 31, 2024 -13.14%
Dec 31, 2023 -4.05%
Sep 30, 2023 0.53%
Jun 30, 2023 1.42%
Mar 31, 2023 40.40%
Dec 31, 2022 -25.35%
Sep 30, 2022 3.73%
Jun 30, 2022 30.00%
Mar 31, 2022 689.47%
Dec 31, 2021 -84.43%
Sep 30, 2021 -25.15%
Jun 30, 2021 83.15%
Mar 31, 2021 17.11%
Dec 31, 2020 153.33%